Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Richard Croft
Delcath SystemsDCTHCOMMENTFeb 11, 2011
Will have an FDA decision in July. Whether they get approval or not, there will be a huge move up or down. Options strategy? Market knows this is going to have an impact so this gets priced into the options. Very difficult to do this.
Richard CroftUnknown
$11.04
Stock price when the opinion was issued
$11.72
As of Jun 12, 2026. Market Open.
Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
Liver cancer treatment. They isolate the liver and then pump more chemo to kill cancer cells. Survivor rate has gone from 4 to 23 months. Market potential is about 5-6 billion globally. Stock dropped when a scientist said it wouldn't work but FDA protocol showed results were significant.
Peter HodsonOwned
Consumer Products
